ES2076437T3 - Analogos de pig y su uso. - Google Patents

Analogos de pig y su uso.

Info

Publication number
ES2076437T3
ES2076437T3 ES91116704T ES91116704T ES2076437T3 ES 2076437 T3 ES2076437 T3 ES 2076437T3 ES 91116704 T ES91116704 T ES 91116704T ES 91116704 T ES91116704 T ES 91116704T ES 2076437 T3 ES2076437 T3 ES 2076437T3
Authority
ES
Spain
Prior art keywords
lys
asn
homoserine
gip
analogues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91116704T
Other languages
English (en)
Inventor
Masayasu Kurono
Takahiko Mitani
Haruo Takahashi
Ryoichi Unno
Tomoo Suzuki
Yuji Hayashi
Yohei Kobayashi
Yoko Ishii
Kiichi Sawai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanwa Kagaku Kenkyusho Co Ltd
Original Assignee
Sanwa Kagaku Kenkyusho Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanwa Kagaku Kenkyusho Co Ltd filed Critical Sanwa Kagaku Kenkyusho Co Ltd
Application granted granted Critical
Publication of ES2076437T3 publication Critical patent/ES2076437T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Lubrication Of Internal Combustion Engines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Holo Graphy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

SE PRESENTAN ANALOGOS DEL PEPTIDO INHIBIDOR GASTRICO (GIP) Y LOS USOS DE LOS MISMOS. LOS ANALOGOS DEL GIP CODIFICAN UNA SECUENCIA DE ACIDO AMINO PRESENTADA POR LA SIGUIENTE FORMULA: EN LA X ES UN RESIDUO DE ACIDO AMINO DIFERENTE A MET, E Y ES A) HOMOSERINA (CON INCLUSION DE LA HEMOSERINA-LACTONA Y QUE SE INDICA POR UN SIMBOLO "HSE", B) AMIDO DE HOMOSERINA (HHSENH SUB 2), C) GLI-LIS-LIS-ASN-ASP-TRP-LIS-HIS-ASN-ILE-THR-GIN-HSE, O D) GLI-LIS-LIS-ASN-ASP-TRP-LIS-HIS-ASN-ILE-THR-GIN-HSENH SUB 2. CADA UNO DE LOS ANALOGOS DEL GIP SE EMPLEA COMO INGREDIENTE EFECTIVO PARA MEDICINAS EN LA CURACION DE LA DIABETES.
ES91116704T 1990-10-05 1991-09-30 Analogos de pig y su uso. Expired - Lifetime ES2076437T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2266438A JPH04145099A (ja) 1990-10-05 1990-10-05 Ｇｉｐ様活性を有するポリペプチド誘導体及びその用途

Publications (1)

Publication Number Publication Date
ES2076437T3 true ES2076437T3 (es) 1995-11-01

Family

ID=17430941

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91116704T Expired - Lifetime ES2076437T3 (es) 1990-10-05 1991-09-30 Analogos de pig y su uso.

Country Status (6)

Country Link
EP (1) EP0479210B1 (es)
JP (1) JPH04145099A (es)
AT (1) ATE123296T1 (es)
DE (1) DE69110101T2 (es)
DK (1) DK0479210T3 (es)
ES (1) ES2076437T3 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE291624T1 (de) 1992-12-16 2005-04-15 Hexima Ltd Ein proteinase inhibitor, vorläufer davon und genetische sequenzen dafür kodierend
EP1119625B1 (en) * 1998-10-07 2005-06-29 Medical College Of Georgia Research Institute, Inc. Glucose-dependent insulinotropic peptide for use as an osteotropic hormone
US20050272652A1 (en) 1999-03-29 2005-12-08 Gault Victor A Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
KR20020097236A (ko) * 2000-04-27 2002-12-31 바이오네브라스카, 인코포레이티드 타입-2 당뇨병, 내당능 장애, 또는 공복 혈당 장애에 대한감수성을 검출하기 위한 위억제성 폴리펩티드 진단 시험
WO2003103697A2 (en) * 2002-06-11 2003-12-18 Cell Therapeutics Scandinavia Ab Use of compounds having gip activity for the treatment of disorders associated with abnormal loss of cells and/or for the treatment of obesity
AU2005298689A1 (en) 2004-10-25 2006-05-04 Cytos Biotechnology Ag Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof
US8263545B2 (en) 2005-02-11 2012-09-11 Amylin Pharmaceuticals, Inc. GIP analog and hybrid polypeptides with selectable properties
KR20070115947A (ko) 2005-02-11 2007-12-06 아밀린 파마슈티칼스, 인크. 선택가능한 특성들을 가지는 ｇｉｐ 유사체 및 하이브리드폴리펩타이드
CA2913805A1 (en) 2005-11-07 2007-05-18 Indiana University Research And Technology Corporation Glucagon analogs exhibiting physiological solubility and stability
RU2477286C2 (ru) 2007-01-05 2013-03-10 Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн АНАЛОГИ ГЛЮКАГОНА, ОБЛАДАЮЩИЕ ПОВЫШЕННОЙ РАСТВОРИМОСТЬЮ В БУФЕРАХ С ФИЗИОЛОГИЧЕСКИМ ЗНАЧЕНИЕМ pH
CA2677932A1 (en) 2007-02-15 2008-08-21 Indiana University Research And Technology Corporation Glucagon/glp-1 receptor co-agonists
MX2010004298A (es) 2007-10-30 2010-05-03 Univ Indiana Res & Tech Corp Compuestos que exhiben actividad antagonista de glucagon y agonista de glp-1.
ES2509883T3 (es) 2007-10-30 2014-10-20 Indiana University Research And Technology Corporation Antagonistas de glucagón
CN102105159B (zh) 2008-06-17 2015-07-08 印第安纳大学研究及科技有限公司 基于gip的混合激动剂用于治疗代谢紊乱和肥胖症
US8450270B2 (en) 2008-06-17 2013-05-28 Indiana University Research And Technology Corporation Glucagon analogs exhibiting enhanced solubility and stability in physiological pH buffers
AR072160A1 (es) 2008-06-17 2010-08-11 Univ Indiana Res & Tech Corp Co-agonistas del receptor de glucagon/glp-1
ES2574835T3 (es) * 2008-08-07 2016-06-22 Ipsen Pharma S.A.S. Análogos del polipéptido insulinotrópico dependiente de glucosa
WO2010016940A2 (en) 2008-08-07 2010-02-11 Ipsen Pharma S.A.S. Analogues of glucose-dependent insulinotropic polypeptide
PE20120332A1 (es) 2008-12-19 2012-04-14 Univ Indiana Res & Tech Corp Profarmacos de peptido de la superfamilia de glucagon basado en amida
EP2443146B1 (en) 2009-06-16 2016-10-05 Indiana University Research And Technology Corporation Gip receptor-active glucagon compounds
US8703701B2 (en) 2009-12-18 2014-04-22 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
KR20120123443A (ko) 2010-01-27 2012-11-08 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 대사 장애 및 비만 치료용 글루카곤 길항제-ｇｉｐ 항진제 콘쥬게이트
MX2012013001A (es) 2010-05-13 2013-02-26 Univ Indiana Res & Tech Corp Peptidos de la superfamilia de glucagon que presentan actividad del receptor nuclear de hormonas.
JP6050746B2 (ja) 2010-05-13 2016-12-21 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションIndiana University Research And Technology Corporation Ｇタンパク質共役受容体活性を示すグルカゴンスーパーファミリーのペプチド
EP2588126A4 (en) 2010-06-24 2015-07-08 Univ Indiana Res & Tech Corp AMID-BASED GLUCAGON SUPERFAMILY PEPTIDE PRODRUGS
US8507428B2 (en) 2010-12-22 2013-08-13 Indiana University Research And Technology Corporation Glucagon analogs exhibiting GIP receptor activity
US9453062B2 (en) 2011-06-10 2016-09-27 Beijing Hanmi Pharmaceutical Co., Ltd. Glucose dependent insulinotropic polypeptide analogs, pharmaceutical compositions and use thereof
RS56173B1 (sr) 2011-06-22 2017-11-30 Univ Indiana Res & Tech Corp Koagonisti receptora za glukagon/glp-1 receptora
KR20140043793A (ko) 2011-06-22 2014-04-10 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 글루카곤/glp-1 수용체 공동-작용물질
JP6324315B2 (ja) 2011-11-17 2018-05-16 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションＩｎｄｉａｎａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ グルココルチコイド受容体の活性を示すグルカゴンスーパーファミリーのペプチド
CN104583232B (zh) 2012-06-21 2018-04-13 印第安纳大学研究及科技有限公司 展现gip受体活性的胰高血糖素类似物
FR2994848B1 (fr) 2012-08-30 2014-08-22 Univ Paris Curie Traitement de l'arthrose par les hormones incretines ou leurs analogues
JOP20190211A1 (ar) 2017-03-31 2019-09-15 Takeda Pharmaceuticals Co ببتيد منشط لمستقبل gip
EP4687947A1 (en) 2023-04-05 2026-02-11 Antag Therapeutics ApS Gip activity modulators and orthostatic intolerance

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01153092A (ja) * 1986-11-27 1989-06-15 Sanwa Kagaku Kenkyusho Co Ltd ヒトガストリツクインヒビトリポリペプチド（ＧＩＰ）前駆体のｃＤＮＡクロ−ン

Also Published As

Publication number Publication date
DE69110101T2 (de) 1996-02-29
DK0479210T3 (da) 1995-07-31
ATE123296T1 (de) 1995-06-15
EP0479210B1 (en) 1995-05-31
EP0479210A3 (en) 1992-09-02
EP0479210A2 (en) 1992-04-08
JPH04145099A (ja) 1992-05-19
DE69110101D1 (de) 1995-07-06

Similar Documents

Publication Publication Date Title
ES2076437T3 (es) Analogos de pig y su uso.
DK0463450T3 (da) Vasoaktive intestinale polypeptid-analoger og udnyttelsen heraf
DE68922405D1 (de) Deletionsanaloga von magaininpeptiden.
NO900824D0 (no) Halogenerte hydrokarbonloesningesmidler og anvendelse derav
DK0618209T3 (da) Pyridothiadiaziner, fremgangsmåder til fremstilling heraf og farmaceutiske sammensætninger indeholdende dem
EP0317645A4 (en) 4H-3,1-BENZOXAZINE-4-ON COMPOUNDS AND SERINE PROTEASE INHIBITING MEDICINAL PRODUCTS.
ATE186302T1 (de) Etoposidanaloge
JPS6416791A (en) Guanidine related compound containing substituted tetraphenylborate ion and its production
FI912336A0 (fi) Omaettade polyesterhartser.
ES2112921T3 (es) Peptidos y anticuerpos para el tratamiento de la artritis reumatoide.
ES2058290T3 (es) Analogos de somatostatina terapeuticos.
AU7993587A (en) The synthesis of peptide aminoalkylamides and peptide hydrazides by the solid-phase method
DK0410278T3 (da) Reninhæmmende aminooligohydroxyderivater
ATE158587T1 (de) Galactosamin-substituierte poly-omega- substituierte l-glutaminsäure und/oder - asparaginsäure
JPS6416792A (en) Guanidine related compound containing tetraphenylborate ion, its production and use thereof in peptide synthesis
ATE158576T1 (de) Alpha-aryl-alpha-hydroxy-beta- imidazolinylpropionsäureamide
ES2062313T3 (es) 13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos.
FI830768A0 (fi) N-/n'-(2-kloretyl)-n'-nitroso-karbamoyl/-oligopeptidester och -amid och foerfarande foer dess framstaellning
ES2141795T3 (es) Procedimiento de preparacion de ureinas derivadas de alfa,omega-diaminoacidos.
ES2001701A6 (es) Un metodo para preparar compuesto de benzoilurea
DE58909745D1 (de) Tetrahydro-4-phenylimino-3-thiophenessigsäuren
ES2083961T3 (es) Acidos 3-anilino-2-hidroxicarbonil-4-tiofenoaceticos.
SU1820511A1 (ru) Пептид для защиты животных от вируса ящура a

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 479210

Country of ref document: ES